The story has been updated to include comments from a conference call.

NEW YORK (GenomeWeb News) – Agilent Technologies and Swedish private equity firm EQT today announced that Agilent will acquire cancer diagnostics firm Dako from EQT for $2.2 billion.

The deal, the largest in Agilent's history, is expected to close within the next 60 days and moves Agilent deeper into the diagnostics space.

Agilent is funding the deal entirely with its off-shore cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.